share_log

科华生物(002022.SZ):上半年净利预降44.00%-59.08%

Kehua Biotech (002022.SZ): Net profit expected to drop 44.00%-59.08% in the first half of the year

Gelonghui Finance ·  07/12/2023 18:17

Gelonghui July 12th 丨Kehua Biotech (002022.SZ) announced its 2023 semi-annual results forecast. Net profit for the reporting period attributable to shareholders of listed companies was 19 million yuan to 26 million yuan, down 44.00%-59.08% from the same period last year; net profit profit after deducting non-recurring profit and loss was 200,000 yuan to 7 million yuan, down 84.37%-100.00% from the same period last year; basic earnings per share profit of 0.0369 yuan/share — 0.0506 yuan/share.

During the reporting period, the company's continuous increase in R&D investment led to an increase in R&D expenses; at the same time, the company made asset impairment preparations for related assets that may be at risk of impairment. Non-recurring profit and loss for the reporting period mainly included interest income on bank structured deposits and government subsidies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment